USPTO 2015–2025 USPTO PatentsView Foreign Corporation

GE Healthcare Bio-science AB

USPTO PatentsView assignee record - 258 granted patents across 68 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

258

Total patents granted

CPC technology areas

14.5

Avg claims per patent

-83%

5-year filing velocity

The verdict

GE holds 258 US patents across 68 technology areas, rank #1,602 of 50,000 tracked assignees.

#1,602
of 50,000 US assignees by volume: Top 9%
by Innovation Score (53.0/100): 14.5
avg claims per patent: -83%
filing velocity, last 5 yrs

Portfolio overview

GE Healthcare Bio-science AB has been granted 258 US utility patents between 2015 and 2024, placing GE Healthcare Bio-science AB at rank #1,602 across all assignees tracked by PlainPatent. This portfolio spans 68 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.5 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, GE Healthcare Bio-science AB is one of the broader-portfolio assignees in the PatentsView dataset. By volume, GE sits between Unify Gmbh & Co. KG (259 patents, rank #1,598) and AAC Acoustic Technologies (shenzhen) Co., Ltd. (257 patents, rank #1,606) - the closest US assignees by grant volume. The composite Innovation Score of 53.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 37 grants, compared with 221 in the 2015–2019 window, a -83% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. GE Healthcare Bio-science AB's 14.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 68 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark GE Healthcare Bio-science AB against peers pursuing similar technology classes.

Unify & KG

259
Workday

259
Box

258
CSC Holdings

258
H Lundbeck A/S

258
Kantatsu

258
Turner Broadcasti…

258
GE Healthcare Bio… ◀

258
AAC Acoustic (She…

257

What this shows GE holds 258 patents at rank #1,602, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GE

By rank, the assignees closest to #1,602 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in GE's primary technology class.

GE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

GE Healthcare Bio-science AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	31	12.0%
2016	48	18.6%
2017	40	15.5%
2018	44	17.1%
2019	58	22.5%
2020	35	13.6%
2021	1	0.4%
2024	1	0.4%

Which technologies does GE Healthcare Bio-science AB patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 125

B01D - SEPARATION 81

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 41

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 32

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 24

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 23

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 21

C07K - PEPTIDES 19

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING 17

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 13

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 13

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 9

G05D - SYSTEMS FOR CONTROLLING OR REGULATING NON-ELECTRIC VARIABLES 7

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 7

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 6

Top 15 of 68 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#1,602

Across all tracked assignees

Innovation Score

53.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does GE Healthcare Bio-science AB hold?

GE Healthcare Bio-science AB holds 258 US granted patents filed between 2015 and 2024, spanning 68 technology areas.

What is GE Healthcare Bio-science AB's Innovation Score?

GE Healthcare Bio-science AB has an Innovation Score of 53.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does GE Healthcare Bio-science AB focus on?

GE Healthcare Bio-science AB's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 125 patents. The company has filed patents in 68 CPC subclasses total.

Is GE Healthcare Bio-science AB's patent filing rate increasing or decreasing?

GE Healthcare Bio-science AB's recent filing velocity is -83% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for GE Healthcare Bio-science AB's patents?

GE Healthcare Bio-science AB's patents average 14.5 claims each. This falls within the standard range, providing solid legal coverage.

How is the GE Healthcare Bio-science AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

GE's 258 grants land it in the top 9% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - GE ranks #1,602 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.